Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation N Cabré, F Luciano-Mateo, S Fernández-Arroyo, G Baiges-Gayà, ... Metabolism 99, 81-89, 2019 | 51 | 2019 |
Prediction of cervical intraepithelial neoplasia grade 2+(CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in … R Ibáñez, J Moreno-Crespi, M Sardà, J Autonell, M Fibla, C Gutiérrez, ... BMC Infectious Diseases 12, 1-8, 2012 | 44 | 2012 |
Protecting the underscreened women in developed countries: the value of HPV test R Ibáñez, J Autonell, M Sardà, N Crespo, P Pique, A Pascual, C Martí, ... BMC cancer 14, 1-8, 2014 | 25 | 2014 |
Understanding the role of circulating chemokine (CC motif) ligand 2 in patients with chronic ischemia threatening the lower extremities A Rull, A Hernandez-Aguilera, M Fibla, J Sepulveda, ... Vascular Medicine 19 (6), 442-451, 2014 | 19 | 2014 |
Chemokine (CC motif) ligand 2 and coronary artery disease: Tissue expression of functional and atypical receptors A Hernández-Aguilera, M Fibla, N Cabré, F Luciano-Mateo, J Camps, ... Cytokine 126, 154923, 2020 | 17 | 2020 |
Plasma energy-balance metabolites discriminate asymptomatic patients with peripheral artery disease A Hernandez-Aguilera, S Fernandez-Arroyo, N Cabre, F Luciano-Mateo, ... Mediators of Inflammation 2018, 2018 | 9 | 2018 |
Nonalcoholic steatohepatitis modifies serum iron-related variables in patients with morbid obesity A Hernández-Aguilera, N Casacuberta, H Castañé, M Fibla, ... Biological Trace Element Research, 1-9, 2021 | 7 | 2021 |
Long-term protection of HPV test in women at risk of cervical cancer R Ibáñez, E Roura, L Monfil, LA Rodríguez, M Sardà, N Crespo, ... Plos one 15 (8), e0237988, 2020 | 7 | 2020 |
Assessment of extracellular matrix-related biomarkers in patients with lower extremity artery disease A Hernández-Aguilera, SH Nielsen, C Bonache, S Fernández-Arroyo, ... Journal of Vascular Surgery 68 (4), 1135-1142. e6, 2018 | 7 | 2018 |
Treating atherosclerosis: targeting risk factors should not be the only option M Fibla, A Hernández-Aguilera, J Camps, JA Menendez, J Joven Annals of Translational Medicine 6 (Suppl 1), 2018 | 2 | 2018 |
Aterosclerosi i citocines: influència de CCL2 i els seus receptors M Fibla Simó Universitat Rovira i Virgili, 0 | | |
SESSIÓ DE CITOTÈCNICS SOCIETAT CATALANA DE CITOPATOLOGIA MF Simó, JFG Fontgivell | | |